Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine
Clinical trial NCT03714555 · TERMINATED
Trial details
- NCT number
- NCT03714555
- Sponsor
- HonorHealth Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2020-07-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.